Steven C Campbell Selected Research

Warm Ischemia

1/2022	What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy?
1/2020	Long-Term Oncologic Outcomes After Laparoscopic and Robotic Tumor Enucleation for Renal Cell Carcinoma.
1/2019	Vascularized Parenchymal Mass Preserved with Partial Nephrectomy: Functional Impact and Predictive Factors.
12/2018	Acute Kidney Injury after Partial Nephrectomy of Solitary Kidneys: Impact on Long-Term Stability of Renal Function.
1/2018	Ischemia and Functional Recovery from Partial Nephrectomy: Refined Perspectives.
10/2017	Functional Comparison of Renal Tumor Enucleation Versus Standard Partial Nephrectomy.
10/2016	Acute Ipsilateral Renal Dysfunction after Partial Nephrectomy in Patients with a Contralateral Kidney: Spectrum Score to Unmask Ischemic Injury.
4/2016	Acute Kidney Injury after Partial Nephrectomy: Role of Parenchymal Mass Reduction and Ischemia and Impact on Subsequent Functional Recovery.
1/2016	Functional Recovery From Extended Warm Ischemia Associated With Partial Nephrectomy.
6/2015	Decline in renal function after partial nephrectomy: etiology and prevention.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven C Campbell Research Topics

Disease

65	Neoplasms (Cancer) 12/2022 - 01/2002
33	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 10/2003
24	Ischemia 01/2020 - 09/2010
15	Kidney Neoplasms (Kidney Cancer) 12/2022 - 01/2009
14	Chronic Renal Insufficiency 12/2022 - 08/2009
12	Hypothermia 01/2022 - 02/2011
9	Solitary Kidney 05/2021 - 09/2010
8	Urinary Bladder Neoplasms (Bladder Cancer) 12/2019 - 07/2007
7	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 09/2010
7	Carcinoma (Carcinomatosis) 01/2017 - 01/2005
5	Neoplasm Metastasis (Metastasis) 07/2013 - 04/2002
4	Disease Progression 11/2018 - 02/2009
4	Prostatic Neoplasms (Prostate Cancer) 05/2010 - 11/2002
3	Chronic Kidney Failure (Chronic Renal Failure) 09/2020 - 10/2016
3	Fibrosis (Cirrhosis) 03/2016 - 07/2008
3	Transitional Cell Carcinoma 10/2010 - 12/2005
2	Proteinuria 12/2022 - 12/2016
2	Thrombosis (Thrombus) 01/2019 - 02/2011
2	Atrophy 06/2015 - 05/2013
2	Hypertrophy 06/2015 - 12/2014
2	Angiomyolipoma 11/2014 - 09/2008
2	Osteoporosis 05/2010 - 11/2009
2	Lymphatic Metastasis 02/2010 - 01/2009
1	Non-Muscle Invasive Bladder Neoplasms 12/2019
1	Muir-Torre Syndrome 01/2017
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2017
1	Tuberous Sclerosis (Bourneville's Disease) 11/2014
1	False Aneurysm (Pseudoaneurysm) 09/2014
1	Albuminuria 03/2014
1	Adrenocortical Carcinoma 05/2013
1	Myocardial Infarction 01/2011
1	Metabolic Bone Diseases (Osteopenia) 05/2010
1	Death (Near-Death Experience) 04/2010
1	Kidney Diseases (Kidney Disease) 03/2010
1	Diverticulum 05/2009
1	Pathologic Complete Response 02/2009
1	Adenocarcinoma 01/2009
1	Cicatrix (Scar) 07/2008
1	Margins of Excision 12/2006

Drug/Important Bio-Agent (IBA)

7	Sunitinib (Sutent)FDA Link 12/2019 - 02/2009
7	CreatinineIBA 12/2018 - 08/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2015 - 06/2007
3	Biomarkers (Surrogate Marker)IBA 05/2015 - 01/2011
2	Biological ProductsIBA 11/2018 - 01/2013
2	Dihydrotachysterol (AT 10)IBA 01/2018 - 07/2013
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2016
2	Bevacizumab (Avastin)FDA Link 11/2010 - 09/2009
2	Sorafenib (BAY 43-9006)FDA Link 11/2010 - 09/2009
2	AndrogensIBA 05/2010 - 11/2009
2	Diphosphonates (Bisphosphonates)IBA 05/2010 - 11/2009
2	Zoledronic Acid (Zometa)FDA Link 05/2010 - 11/2009
2	Cisplatin (Platino)FDA LinkGeneric 07/2009 - 02/2009
2	Hormones (Hormone)IBA 01/2006 - 01/2005
2	Peptides (Polypeptides)IBA 10/2004 - 04/2002
1	Antihypertensive Agents (Antihypertensives)IBA 05/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2019
1	4- propionyloxy- 4- phenyl- N- methylpiperidineIBA 01/2019
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 03/2018
1	cellulose acetate-butyrate (C.A.B.)IBA 01/2018
1	Capsules (Microcapsules)IBA 10/2017
1	Tyrosine Kinase InhibitorsIBA 12/2016
1	Indicators and Reagents (Reagents)IBA 12/2016
1	pazopanib FDA Link 08/2015
1	Hemostatics (Antihemorrhagics)IBA 06/2015
1	trans-sodium crocetinate (crocetin)IBA 11/2014
1	Fenoldopam (Corlopam)FDA LinkGeneric 02/2013
1	EnzymesIBA 01/2011
1	Iothalamic Acid (Iotalamic Acid)FDA Link 03/2010
1	Interleukin-2 (IL2)IBA 09/2009
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2009
1	Hematoxylin (Haematoxylon)IBA 05/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2009
1	Methotrexate (Mexate)FDA LinkGeneric 02/2009
1	Vinblastine (Vinblastine Sulfate)FDA Link 02/2009
1	Cadherins (E-Cadherin)IBA 01/2009
1	beta CateninIBA 01/2009
1	Midazolam (Versed)FDA LinkGeneric 12/2008
1	Interferon-alpha (Interferon Alfa)IBA 06/2007
1	Phosphotransferases (Kinase)IBA 05/2006
1	Estrogens (Estrogen)FDA Link 01/2006
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2006

Therapy/Procedure

77	Nephrectomy 12/2022 - 10/2003
19	Warm Ischemia 01/2022 - 09/2010
18	Therapeutics 12/2019 - 01/2006
10	Cystectomy 01/2014 - 12/2005
4	Immunotherapy 01/2021 - 10/2003
4	Molecular Targeted Therapy 01/2018 - 01/2007
3	Drug Therapy (Chemotherapy) 12/2019 - 07/2009
3	Neoadjuvant Therapy 01/2019 - 02/2009
3	Metastasectomy 02/2011 - 10/2003
3	Cryosurgery 01/2011 - 10/2003
2	Nephroureterectomy 01/2020 - 06/2010
2	Adrenalectomy 05/2013 - 06/2009
2	Lymph Node Excision (Lymph Node Dissection) 08/2009 - 12/2006
1	Radiotherapy 12/2019
1	Overlapping Surgery 03/2019
1	Conservative Treatment 07/2011
1	Aftercare (After-Treatment) 02/2011
1	Salvage Therapy 12/2008
1	Radiofrequency Ablation 07/2008